<p>Nhtt150Q-EGFP cells transfected with control (NSC) or shRNAs for indicated genes were treated with 0.5 μM MG132, 0.5 μM Baf A1 or DMSO together with ponasterone A for 24 hr. The cells with Nhtt150Q-EGFP aggregates were quantified by ArrayScan reader. Some of shRNA's suppressive effects on the aggregation were relieved by treatment with MG132 but not with Baf A1. Values are means ± SD of four well data (*<i>P</i><0.05, **<i>P</i><0.01, ***<i>P</i><0.001).</p
<p>(A) With or without 1 µM MG 132 pretreatment for 30 min and following the presence or absence of ...
<p><b>(A)</b> Western blot analysis and quantification of FL-SMN and a-SMN protein expression after ...
<p>THP-1 cells, expressing either non-targeting control shRNA (<b>A–C</b>), or PTPN22 targeting shRN...
<p>(A) Summarized data of the first screening using Nhtt150Q-EGFP cells. Mean z-score of 11346 shRNA...
<p>Total 11346 shRNA clones were subjected to the first screening using Nhtt150Q-EGFP cells. The scr...
<p>(A, B) Nhtt150Q-EGFP cells were transfected with miRNA expression vector. After 2 days, cells wer...
<p>HeLa cells treated with 20 µM MG-132 in DMSO for 1.5 hours, 2.5 hours, 5 hours, and 8 hours showe...
<p>(A) SW480 cells stably expressing GFP-TNKS1 were treated with DMSO, G007-LK or MG132 alone or in ...
<p>The proteasome inhibitor MG-132 down-regulates (−) the ubiquitin-proteasome pathway (UPP). AMPK-a...
<p>A, Effect of GNA on the flux of autophagy. GFP-LC3/HeLa cells were cultured in the absence (contr...
<p>(A) Neuro2a cells were transfected with siRNAs for NT (non-targeting), Tcf20 (OBS or Inv-1), Csnk...
<p>Intracellular ATP production of HeLa cells (<b>A</b>) infected with scrambled RNA, Mfn2 shRNA, or...
<p>(A) With or without 1 µM H-89 pretreatment for 30 min, pHtt-109Q-mKate-transfected cells were tre...
<p>(A) 24h post transfection, cells were treated with 10 μM MG132 (MG) or 100 μM chloroquine (Chlor)...
<p>(A) M28 and REN spheroids were transfected with ATG5 (left panels) and ATG7 siRNA (right panels) ...
<p>(A) With or without 1 µM MG 132 pretreatment for 30 min and following the presence or absence of ...
<p><b>(A)</b> Western blot analysis and quantification of FL-SMN and a-SMN protein expression after ...
<p>THP-1 cells, expressing either non-targeting control shRNA (<b>A–C</b>), or PTPN22 targeting shRN...
<p>(A) Summarized data of the first screening using Nhtt150Q-EGFP cells. Mean z-score of 11346 shRNA...
<p>Total 11346 shRNA clones were subjected to the first screening using Nhtt150Q-EGFP cells. The scr...
<p>(A, B) Nhtt150Q-EGFP cells were transfected with miRNA expression vector. After 2 days, cells wer...
<p>HeLa cells treated with 20 µM MG-132 in DMSO for 1.5 hours, 2.5 hours, 5 hours, and 8 hours showe...
<p>(A) SW480 cells stably expressing GFP-TNKS1 were treated with DMSO, G007-LK or MG132 alone or in ...
<p>The proteasome inhibitor MG-132 down-regulates (−) the ubiquitin-proteasome pathway (UPP). AMPK-a...
<p>A, Effect of GNA on the flux of autophagy. GFP-LC3/HeLa cells were cultured in the absence (contr...
<p>(A) Neuro2a cells were transfected with siRNAs for NT (non-targeting), Tcf20 (OBS or Inv-1), Csnk...
<p>Intracellular ATP production of HeLa cells (<b>A</b>) infected with scrambled RNA, Mfn2 shRNA, or...
<p>(A) With or without 1 µM H-89 pretreatment for 30 min, pHtt-109Q-mKate-transfected cells were tre...
<p>(A) 24h post transfection, cells were treated with 10 μM MG132 (MG) or 100 μM chloroquine (Chlor)...
<p>(A) M28 and REN spheroids were transfected with ATG5 (left panels) and ATG7 siRNA (right panels) ...
<p>(A) With or without 1 µM MG 132 pretreatment for 30 min and following the presence or absence of ...
<p><b>(A)</b> Western blot analysis and quantification of FL-SMN and a-SMN protein expression after ...
<p>THP-1 cells, expressing either non-targeting control shRNA (<b>A–C</b>), or PTPN22 targeting shRN...